Nuclear gene defects in mitochondrial disorders

被引:0
|
作者
Zeviani M. [1 ]
Corona P. [2 ]
Nijtmans L. [1 ]
Tiranti V. [2 ]
机构
[1] C. Besta National Neurological Institute, 1-20133 Milan
[2] Department of Molecular and Cellular Biology, Section of Molecular Biology, University of Amsterdam, Amsterdam
来源
关键词
Oxidative Phosphorylation; Respiratory Chain; Nuclear Gene; Mutant Cell; Null Mutant;
D O I
10.1007/s100720050059
中图分类号
学科分类号
摘要
An increasing number of nuclear genes have been associated with abnormalities of oxidative phosphorylation and mitochondrial disorders. The protein products of these genes can be grouped into three categories: structural components of the respiratory chain, factors influencing the structural integrity or the copy number of mitochondrial DNA, and proteins which control the formation, assembly and turnover of the respiratory complexes. Loss-of-function mutations in SURF-1, a gene belonging to the third category, have been associated with Leigh syndrome with cytochrome c oxidase deficiency. Mature Surf-1 protein (Surf-lp) is a 30 kDa hydrophobic polypeptide whose function is still unknown. Using antibodies against human Surflp, we demonstrated that this protein is imported into mitochondria as a larger precursor. The same analysis revealed that no protein is present in cell lines harboring loss-of-function mutations of SURF-1, regardless of their type and position. We also generated several constructs with truncated or partially deleted SURF-1 cDNAs. None of these constructs, expressed into SURF-1 null mutant cells, were able to rescue the COX phenotype, suggesting that different regions of the protein are all essential for function. Finally, experiments based on 2D gel electrophoresis indicated that assembly of COX in SURF-1 null mutants is blocked at an early step, most likely before the incorporation of subunit II in the nascent intermediates composed of subunit I alone or subunit I plus subunit IV. © Springer-Verlag 1999.
引用
收藏
页码:401 / 408
页数:7
相关论文
共 50 条
  • [1] Nuclear gene defects in mitochondrial disorders
    Zeviani, M
    Corona, P
    Nijtmans, L
    Tiranti, V
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 20 (06): : 401 - 408
  • [2] Mitochondrial Disorders Due to Nuclear OXPHOS Gene Defects
    Ugalde, Cristina
    Moran, Maria
    Blazquez, Alberto
    Arenas, Joaquin
    Martin, Miguel A.
    INHERITED NEUROMUSCULAR DISEASES: TRANSLATION FROM PATHMECHANISMS TO THERAPIES, 2009, 652 : 85 - 116
  • [3] Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects
    Leonard, JV
    Schapira, AHV
    LANCET, 2000, 355 (9201): : 389 - 394
  • [4] Mitochondrial disorders due to defects in nuclear genes
    Zeviani, Massimo
    NEUROMUSCULAR DISORDERS, 2006, 16 : S54 - S54
  • [5] Nuclear gene defects in respiratory chain disorders
    Shoubridge, EA
    SEMINARS IN NEUROLOGY, 2001, 21 (03) : 261 - 267
  • [6] 2-LOCUS MITOCHONDRIAL AND NUCLEAR GENE MODELS FOR MITOCHONDRIAL DISORDERS
    BU, XD
    YANG, HY
    SHOHAT, M
    ROTTER, JI
    GENETIC EPIDEMIOLOGY, 1992, 9 (01) : 27 - 44
  • [7] The expanding spectrum of nuclear gene mutations in mitochondrial disorders
    Zeviani, M
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2001, 12 (06) : 407 - 416
  • [8] POLG-related disorders Defects of the nuclear and mitochondrial genome interaction
    Milone, Margherita
    Benarroch, Eduardo E.
    Wong, Lee-Jun
    NEUROLOGY, 2011, 77 (20) : 1847 - 1852
  • [9] Gene therapy strategies for rare monogenic disorders with nuclear or mitochondrial gene mutations
    Wang, Yi
    Hu, Li-Fan
    Zhou, Tian-Jiao
    Qi, Lian-Yu
    Xing, Lei
    Lee, Jaiwoo
    Wang, Feng-Zhen
    Oh, Yu-Kyoung
    Jiang, Hu-Lin
    BIOMATERIALS, 2021, 277
  • [10] ASSOCIATIONS OF NUCLEAR-ENCODED MITOCHONDRIAL GENE VARIANTS WITH PSYCHIATRIC DISORDERS
    Choi, Jaehyoung
    Chaumette, Boris
    Frye, Mark A.
    Goncalves, Vanessa F.
    Kennedy, James L.
    Leboyer, Marion
    Mueller, Daniel J.
    Ophoff, Roel
    Papiol, Sergi
    Vawter, Marquis P.
    Faraone, Stephen V.
    Andreazza, Ana C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2024, 87 : 158 - 159